logo
Share SHARE
FONT-SIZE Plus   Neg

Crocs Profit Rises, But Stock Down On Weak Outlook

Shoe maker Crocs, Inc. (CROX), Wednesday reported an increase in first-quarter profit, on higher gross margins and a 20 percent jump in revenues driven by sales in Asia and Americas. Both earnings and revenue for the quarter came in ahead of analysts' expectations.

Nevertheless, shares of Crocs dropped over 5 percent following a weak outlook for the second quarter, with both earnings and revenue expected to fall short of current Wall Street estimates.

First-quarter revenues of Crocs grew 19.9 percent, driven mostly by sales in Asia and Americas, somewhat offset by a decrease in Europe. Revenue increased 17.1 percent for the Americas, while Asia revenues jumped 40.5 percent. Europe sales declined 2.7 percent.

Crocs' first-quarter global same store sales increased 10.2 percent on a currency neutral basis. Wholesale sales increased 15.9 percent, while retail sales improved 33.2 percent.

The Niwot, Colorado-based company ended the quarter with 439 retail store locations, compared to 371 locations a year ago.

Crocs President and CEO John McCarvel observed, "Our approximate 20 percent top-line sales growth in the quarter was broad-based across channels and regions, with only European wholesale performance lagging primarily due to macroeconomic headwinds in the region."

Gross profit, as a percentage of sales, for the quarter increased to 53.3 percent from 52.6 percent in the corresponding quarter last year.

Crocs' first-quarter net income increased to $28.3 million or $0.31 per share from $21.5 million or $0.24 per share in the similar quarter last year. On average, seven analysts polled by Thomson Reuters expected earnings of $0.26 per share for the quarter.

Revenue for the quarter surged 19.9 percent to $271.8 million from $226.7 million a year ago. Six analysts had a consensus revenue estimate of $266.52 million for the quarter.

Looking ahead to the second-quarter 2012, Crocs expects earnings in the range of $0.61 to $0.63 per share. Nine analysts on consensus currently expect earnings of $0.65 per share for the quarter.

Revenues for the second quarter are projected in the range of $335 million to $340 million, well below the current Street estimate of $352.69 million.

CROX closed Wednesday's regular trading at $22.04, up $0.55 or 2.56%, on a volume of 3.34 million shares on the Nasdaq. In after-hours, the stock dropped 5.40% to trade at $20.85.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT